Targeting Pancreatic Cancer Cells with Peptide-Functionalized Polymeric Magnetic Nanoparticles
Pancreatic cancer is a concealed and highly malignant tumor, and its early diagnosis plays an increasingly weighty role during the course of cancer treatment. In this study, we developed a polymeric magnetic resonance imaging (MRI) nanoplatform for MRI contrast agents. To improve tumor-targeting del...
Main Authors: | Xiuliang Zhu, Nan Lu, Ying Zhou, Shaoyan Xuan, Jiaojiao Zhang, Francesca Giampieri, Yongping Zhang, Fangfang Yang, Risheng Yu, Maurizio Battino, Zuhua Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/12/2988 |
Similar Items
-
Lanthanide DO3A-Complexes Bearing Peptide Substrates: The Effect of Peptidic Side Chains on Metal Coordination and Relaxivity
by: Sophie Laine, et al.
Published: (2021-04-01) -
Development of a Pancreatic Cancer Specific Binding Peptide Using Phage Display
by: Dong Won Lee, et al.
Published: (2019-07-01) -
Peptide-Based Soft Hydrogels Modified with Gadolinium Complexes as MRI Contrast Agents
by: Enrico Gallo, et al.
Published: (2020-01-01) -
A Neoantigen-Based Peptide Vaccine for Patients With Advanced Pancreatic Cancer Refractory to Standard Treatment
by: Zheling Chen, et al.
Published: (2021-08-01) -
Pancreatic tumor in type 1 autoimmune pancreatitis: a diagnostic challenge
by: Pei Xiang, et al.
Published: (2019-08-01)